Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Swerdlow

Showing results (11-20 of 417) with videos related to

Pageof 42
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|October 7, 2006
Does growth hormone therapy increase the risk of cancer?Anthony J Swerdlow
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1993
Cohorts of insulin-treated patients with diabetesA J Swerdlow
European Urology|January 1, 1993
The epidemiology of testicular cancerA J Swerdlow
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2003
Epidemiology of Hodgkin's disease and non-Hodgkin's lymphomaA J Swerdlow
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 13, 2001
Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatmentA J Swerdlow
British Medical Journal|November 24, 1979
Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshineA J Swerdlow
Annals of the New York Academy of Sciences|January 1, 1990
International trends in cutaneous melanomaA J Swerdlow
British Journal of Cancer|May 1, 1989
Interpretation of England and Wales cancer mortality data: the effect of enquiries to certifiers for further informationA J Swerdlow
British Journal of Cancer|December 1, 1985
Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford RegionA J Swerdlow
Journal of Epidemiology and Community Health|March 1, 1988
The value of England and Wales congenital malformation notification scheme data for epidemiology: male genital tract malformationsA J Swerdlow, D Melzer
Pageof 42

Showing results (11-20 of 417) with videos related to

Sort By:
Pageof 42
Nature Clinical Practice. Endocrinology & Metabolism|October 7, 2006
Does growth hormone therapy increase the risk of cancer?Anthony J Swerdlow
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1993
Cohorts of insulin-treated patients with diabetesA J Swerdlow
European Urology|January 1, 1993
The epidemiology of testicular cancerA J Swerdlow
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2003
Epidemiology of Hodgkin's disease and non-Hodgkin's lymphomaA J Swerdlow
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 13, 2001
Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatmentA J Swerdlow
British Medical Journal|November 24, 1979
Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshineA J Swerdlow
Annals of the New York Academy of Sciences|January 1, 1990
International trends in cutaneous melanomaA J Swerdlow
British Journal of Cancer|May 1, 1989
Interpretation of England and Wales cancer mortality data: the effect of enquiries to certifiers for further informationA J Swerdlow
British Journal of Cancer|December 1, 1985
Seasonality of presentation of cutaneous melanoma, squamous cell cancer and basal cell cancer in the Oxford RegionA J Swerdlow
Journal of Epidemiology and Community Health|March 1, 1988
The value of England and Wales congenital malformation notification scheme data for epidemiology: male genital tract malformationsA J Swerdlow, D Melzer
Pageof 42